Coordination of Care Among Physical Therapists and Neurologists in Huntington Disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 19, 2021
- Accepted July 18, 2022
- First Published August 24, 2022.
Article Versions
- Previous version (August 24, 2022 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Nora E. Fritz, PhD, PT, DPT, NCS,
- Deb Kegelmeyer, MS, PT, DPT, GCS,
- Ashwini K. Rao, EdD, OTR/L, FAOTA,
- Lori Quinn, EdD, PT,
- Martha A. Nance, MD and
- Anne Kloos, PhD, PT, NCS
- Nora E. Fritz, PhD, PT, DPT, NCS,
(1) Served on MS Scientific Advisory Board for Helius Medical<br>(2) Serve on the DSMB of an R33 Grant at my University
NONE
(1) Honoraria provided from the study Sponsors - Huntington <br>Study Group, European Huntington Disease Network, The Griffin <br>Foundation<br>(2) Honoraria for speaking at Consortium of Multiple Sclerosis <br>Centers Annual Meeting
(1) Journal of Neurologic Physical Therapy
NONE
NONE
(1) Employed at Wayne State University, Associate Professor, <br>2015- present.
(1) TEVA
NONE
NONE
NONE
(1) TEVA #TV50717-NDG-60338 - PI - 2022-2023
(1) NIH #HD102337 - CoPI - 2021-2026
NONE
(1) National Multiple Sclerosis Society # RG2111-38718 - <br>2022-2025<br>(2) National Multiple Sclerosis Society #PP-1912-35300 - <br>2020-2021<br>(3) Consortium of Multiple Sclerosis Centers Pilot Grant - <br>2020-2021
NONE
NONE
NONE
NONE
NONE
NONE
- Deb Kegelmeyer, MS, PT, DPT, GCS,
None
NONE
None
NONE
NONE
1. Medbridge - I receive royalties for online continuing <br>education courses that I created. 2016 to present<br>McGraw-Hill Publishing - I receive royalties for authorship <br>of a book 2016 to present
NONE
I do consultant work with Create a Better You which is owned <br>by Neuvanta LLC
NONE
I am on the board of Neuvanta LLC
NONE
Honda R&D - I have done research related to exoskeleton <br>robotic devices for clients with stroke that is funded <br>through Honda R&D. Money is received in the form of release <br>time paid to Ohio State University.
NONE
NONE
Michael J Fox Foundation - I am an investigator on a study <br>funded by the MJFF.
NONE
NONE
NONE
NONE
NONE
Multiple legal firms since 2005. The primary firm for which <br>I <br>have done expert testimony is Reminger
- Ashwini K. Rao, EdD, OTR/L, FAOTA,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
Non-profit entity: Huntington's Disease Society of America
NONE
NONE
NONE
National Science Foundation, Grant No: 1838725. Role: PI. Years: 4<br>National Institute of Health, Grant No: R56AG061817. Role: Co-PI. Years: 1<br>New York State Department of Health. Grant No: DOH01-C31425GG-3450000. <br>Role: Co-I. Years: 5<br>National Institute of Health, Grant No: U01NS055903. Role: Site PI. Years: 4<br>National Institute of Health, Grant No: U01NS113851. Role: Site PI. Years: 5
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Lori Quinn, EdD, PT,
None
NONE
(1) Huntington Study Group, stipend
(1) Physical Therapy Journal, Editorial Board member, 2017-present<br>(2) Journal of Huntington's Disease, Associate Editor,2017-present
NONE
(1) Documentation for Rehabilitation: A guide to clinical decision making in physical therapy. Elsevier Publishing Company
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Huntington Disease Study Group<br>(2) Jacques and Gloria Gossweiller Foundation<br>(3) Parkinson's Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Martha A. Nance, MD and
Executive Committee Huntington Study Group<br>Roche HDGENERATION1 DSMB<br>Uniqure DSMB<br>Novartis SAB
NONE
spouse received travel funding from Novocure<br>I have received travel funding from Huntington Study Group<br>I have received travel funding/honoraria from Parkinson <br>Study Group<br>I have received travel funding from Roche<br>I have received travel funding/speaker honorarium from <br>Parkinson's Foundation<br>I have received travel funding from Huntington Disease <br>Society of America<br>I received travel funding/speaker honorarium from <br>American Academy of Neurology
Associate Editor, Journal of Huntington's Disease 2012-<br>present<br>Editorial board, Journal of Clinical Movement Disorders, <br>2020-present
NONE
chapter in Juvenile Huntington's disease and other <br>trinucleotide repeat disorders, Oxford University Press, <br>2009
NONE
NONE
NONE
NONE
NONE
TEVA<br>Neurocrine
NONE
NONE
Huntington's Disease Society of America<br>Parkinson's Foundation<br>CHDI<br>Park Nicollet Institute
NONE
NONE
NONE
NONE
NONE
NONE
- Anne Kloos, PhD, PT, NCS
None
NONE
None
Associate Editor of Journal of Neurologic Physical Therapy
NONE
Medbridge Continuing Education courses<br>Neurologic Rehabilitation, McGraw Hill Education, 2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Michael J. Fox Foundation, Huntington's Disease Society of <br>America
NONE
NONE
NONE
NONE
NONE
NONE
- Program in Physical Therapy (NEF), Wayne State University, Detroit MI; Physical Therapy Division (DK, AK), School of Health and Rehabilitation Sciences, The Ohio State University, Columbus; Program in Physical Therapy (AKR), Department of Rehabilitative and Regenerative Medicine, G.H. Sergievsky Center, Columbia University, New York; Department of Biobehavioral Sciences (LQ), Teachers College, Columbia University, New York; and Hennepin County Medical Center (MAN), Minneapolis.
- Correspondence
Dr. Fritz nora.fritz{at}wayne.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.